PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease

International Journal of Cancer

Volumn 111, Issue 2, 2004, Pages 218-223

  Matsumura, Yasuhiro ^a,b   Matsumura, Yumi ^a   Nishigori, Chikako ^c   Horio, Takeshi ^b   Miyachi, Yoshiki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CDNA microarray; Extramammary Paget's disease; In situ hybridization; P53; PIG7 LITAF

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER GENETICS; DNA MICROARRAY; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; LITAF GENE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PAGET BONE DISEASE; PIG7 GENE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SINGLE STRAND CONFORMATION POLYMORPHISM; UNINDEXED SEQUENCE;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAGET'S DISEASE, EXTRAMAMMARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 3142733520     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20251     Document Type: Article

References (22)

1. Jaworsky C. Extramammary Paget's disease. In: Miller SJ, Maloney ME, eds. Cutaneous oncology. Oxford: Blackwell, 1998. 789-95.
2. Nishi M, Yoshida H, Setoyama M, Tashiro M. Immunohistochemical study of c-erb B-2 oncoprotein expression in extramammary Paget's disease. Dermatology 1994;188:100-2.
3. Scheistroen M, Trope C, Kaern J, Pettersen EO, Alfsen GC, Nesland JM. DNA ploidy and expression of p53 and c-erbB-2 in extramammary Paget's disease of the vulva. Gynecol Oncol 1997;1:88-92.
4. Takata M, Hatta N, Takehara K. Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several loci implicated in other cancers. Br J Cancer 1997;76:904-8.
5. Song S, MacLachlan TK, Meng RD, El-Deiry WS. Comparative gene expression profiling in response to p53 in a human lung cancer cell line. Biochem Biophys Res Commun 1999;264:891-5.
6. Gentile M, Ahnstrom M, Schon F, Wingren S. Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis. Oncogene 2001;20:7753-60.
7. Ricketts SL, Carter JC, Coleman WB. Identification of three 11p11.2 candidate liver tumor suppressors through analysis of known human genes. Mol Carcinog 2003;36:90-9.
8. Street VA, Bennett CL, Goldy JD, Goldy JD, Shirk AJ, Kleopa KA, Tempel BL, Lipe HP, Scherer SS, Bird TD, Chance PF. Mutation of a putative protein degradation gene LITAF/SIMPLE in CharcotMarie-Tooth disease IC. Neurology 2003;60:22-6.
9. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997;389:300-5.
10. Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet 1998;7:969-74.
11. Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 1997;108:6-12.
12. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
13. Sato M, Nishigori C, Yagi T, Takebe H. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation. Mutat Res 1996;362:199-208.
14. Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. Hum Mutat 1999;14:1-8.
15. Wyllie A. Clues in the p53 murder mystery. Nature 1997;389:237-8.
16. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:389-90.
17. de Vries A, Flores ER, Miranda B, Hsieh HM, van Oostrom CTM, Sage J, Jacks T. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc Natl Acad Sci USA 2002;99:2948-53.
18. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 2000;910:121-37.
19. Myokai F, Takashiba S, Lebo R, Amar S. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci USA 1999;96:4518-23.
20. Murrel TW, McMullan FH. Extramammary Paget's disease: a report of two cases. Arch Dermatol 1962;85:600-13.
21. Jones RE, Austin C, Ackerman AB. Extramammary Paget's disease. Am J Dermatopathol 1979;1:101-32.
22. Bohem F, Morris J. Paget's disease and apocrine gland carcinoma of the vulva. Obstet Gynecol 1971;39:185-92.